AnaptysBio, Inc. short interest in 2025
In 2025, AnaptysBio, Inc.'s disclosed short interest ran from 21.68% of shares outstanding on 15 Jan 2025 to 18.57% on 31 Dec 2025, a change of -3.11 percentage points. The year's high was 35.38% on 15 Apr 2025 and its low 18.57% on 31 Dec 2025, averaging 28.49% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.69 days on 29 Aug 2025. Full history: AnaptysBio, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 21.68% (15 Jan 2025)
- End of year
- 18.57% (31 Dec 2025)
- Change
- -3.11 pp
- High
- 35.38% (15 Apr 2025)
- Low
- 18.57% (31 Dec 2025)
- Average
- 28.49%
- Highest days to cover
- 25.69 (29 Aug 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 21.68% | 9.98 | |
| 31 Jan 2025 | 19.83% | 8.70 | |
| 14 Feb 2025 | 30.59% | 4.25 | |
| 28 Feb 2025 | 29.68% | 12.82 | 10-K filed, results (8-K) |
| 14 Mar 2025 | 32.21% | 13.45 | |
| 31 Mar 2025 | 35.28% | 10.12 | |
| 15 Apr 2025 | 35.38% | 12.10 | |
| 30 Apr 2025 | 30.50% | 15.56 | |
| 15 May 2025 | 30.06% | 18.80 | 10-Q filed, results (8-K) |
| 30 May 2025 | 31.34% | 14.73 | |
| 13 Jun 2025 | 31.16% | 10.39 | |
| 30 Jun 2025 | 31.87% | 19.55 | |
| 15 Jul 2025 | 31.93% | 18.23 | |
| 31 Jul 2025 | 32.55% | 18.82 | |
| 15 Aug 2025 | 34.27% | 18.81 | 10-Q filed, results (8-K) |
| 29 Aug 2025 | 34.64% | 25.69 | |
| 15 Sep 2025 | 33.61% | 18.31 | |
| 30 Sep 2025 | 25.58% | 7.93 | |
| 15 Oct 2025 | 25.38% | 15.38 | |
| 31 Oct 2025 | 24.74% | 23.06 | |
| 14 Nov 2025 | 21.42% | 7.21 | 10-Q filed, results (8-K) |
| 28 Nov 2025 | 21.18% | 8.83 | |
| 15 Dec 2025 | 20.38% | 12.54 | |
| 31 Dec 2025 | 18.57% | 12.15 |
See also: AnaptysBio, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.